New Study Results Presented at ASCO Supports DiviTum® for Monitoring Advanced Breast Cancer Treatment - Biovica International AB |
| May 17, 2018 | May 2018 Bond Updates |
|
STOCKHOLM, May 17, 2018 /PRNewswire/ -- The EFECT-study evaluated standard hormonal therapies for women with advanced breast cancer and DiviTum® was used as a non-invasive tool for monitoring therapy response. 244 patients had blood samples analyzed with DiviTum® in a collaboration... |
| View more at: https://www.prnewswire.com/news-releases/new-study-results-presented-at-asco-supports-divitum-for-monitoring-advanced-breast-cancer-treatment---biovica-international-ab-300650153.html |
| Related News |
|